News:
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal - Merck says Keytruda injection on par with approved IV version in trial - Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall - Merck says experimental RSV treatment protected infants in trial, paving way for potential approval - Stocks making the biggest premarket moves: Boeing, Dell, Merck and more - Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion - Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion - Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda - Stocks making the biggest moves premarket: CrowdStrike, Merck, PayPal, JetBlue and more - Merck is betting on AI partnerships to develop new drugs, but refraining from bringing in external expertise through acquisitions.
Merck
Bookmark
ShareKey facts
- city: Kenilworth
- state: NJ
- country: United States
- sector: Health Care
- foundation year: 1891
- industry: Pharmaceuticals
- CEO: Robert M. Davis J.D.
- CEO gender: Male
Classified as: organization
Summary
Merck is a company. It is located in Kenilworth, the United States and was founded in 1891. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Business
Merck is one of the companies in the United States, companies in Pharmaceuticals, companies in Health Care and 3,466,499 companies in our database.
- Assets: 105.7B $
- Debt: 31.8B $
- Employees: 67,000 people
- Free cash flow: -23802600 $
- Market cap: 219.8B $
- Profits: 13B $
- Revenues: 57.2B $
Stocks from Merck
Explore more on business
Talking Points:
- Merck | Home
- At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
- @Merck's account has been withheld in Switzerland, Australia, United Kingdom, Singapore, Ireland, India in response to a legal demand. Learn more.
- At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive ...
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Learn more about talking points